Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

about

Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting.

P2860

Q35763883-C87D45B1-A8E7-433D-BBA0-C9810435504A

P2860

Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q35045933

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

@en

type

Item

label

Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

@en

prefLabel

Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

@en

P1476

Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

@en

P2093

A Gheorghe

http://www.w3.org/2001/XMLSchema#string

C Tiu

http://www.w3.org/2001/XMLSchema#string

E Rezus

http://www.w3.org/2001/XMLSchema#string

G Udrea

http://www.w3.org/2001/XMLSchema#string

S Sovaila

http://www.w3.org/2001/XMLSchema#string

V Stoica

http://www.w3.org/2001/XMLSchema#string

P2860

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.

Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS).

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

P304

588-594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Purcarea

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25713628

http://www.w3.org/2001/XMLSchema#string

P932

4316145

http://www.w3.org/2001/XMLSchema#string

Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

about

P2860

P2860

Utility of different cardiovascular disease prediction models in rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932